Severe hypokalaemia with paralysis induced by small doses of liquorice.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMC 2425815)

Published in Postgrad Med J on July 01, 1980

Authors

A M Cumming, K Boddy, J J Brown, R Fraser, A F Lever, P L Padfield, J I Robertson

Articles cited by this

Inhibition of the "mineralocorticoid" activity of licorice by spironolactone. J Clin Endocrinol Metab (1962) 3.62

A liquorice extract with deoxycortone-like action. Lancet (1950) 3.51

Body Composition: Studies in the Human Being by the Dilution Principle. Science (1952) 3.27

Hypokalaemia, flaccid quadruparesis, and myoglobinuria with carbenoxolone (biogastrone). Br Med J (1966) 3.20

Hypokalemic myopathy with myoglobinuria associated with licorice ingestion. N Engl J Med (1966) 2.03

The estimation of renin in human plasma. Biochem J (1964) 1.85

A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med (1973) 1.76

Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br Med J (1977) 1.68

Preparation of glycyrrhizinic acid, the electrolyte-active principle of licorice: its effects upon metabolism and upon pituitary-adrenal function in man. J Lab Clin Med (1956) 1.67

The measurement of exchangeable sodium in man using the isotope 24Na. Clin Sci (Lond) (1953) 1.63

Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity. JAMA (1968) 1.58

Liquorice toxicity and the renin-angiotensin-aldosterone axis in man. Br Med J (1977) 1.56

Muscle paresis and hypokalemia after treatment with duogastrone. Br Med J (1969) 1.40

Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na. Metabolism (1973) 1.28

Cardiac arrest due to liquoriceinduced hypokalaemia. Br Med J (1977) 1.04

Estimation of total body sodium by isotopic dilution. II. Studies on infants and children: an example of a constant differential growth ratio. J Clin Invest (1951) 1.02

Pseudohyperaldosteronism induced by habitual ingestion of liquorice. Postgrad Med J (1970) 0.94

Articles by these authors

The academic base for general practice: the case for change. BMJ (1993) 5.25

Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet (1992) 4.18

Captopril in the treatment of clinical hypertension and cardiac failure. Lancet (1979) 3.93

The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens (1990) 3.89

Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ (1989) 3.74

Detection of coronary stenoses on source and projection images using three-dimensional MR angiography with retrospective respiratory gating: preliminary experience. AJR Am J Roentgenol (1998) 3.58

Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ (2000) 3.37

Examination of clinical examiners. Lancet (1969) 3.07

Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) (1983) 2.90

Foetal respiratory movements, electrocortical and cardiovascular responses to hypoxaemia and hypercapnia in sheep. J Physiol (1974) 2.88

Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74

Fetal breathing. Br Med Bull (1975) 2.70

Inhaled corticosteroids, bone formation, and osteocalcin. Lancet (1991) 2.45

Does participating in physical activity in outdoor natural environments have a greater effect on physical and mental wellbeing than physical activity indoors? A systematic review. Environ Sci Technol (2011) 2.45

A model for clinical governance in primary care groups. BMJ (1999) 2.44

Pituitary ablation for diabetic retinopathy. Q J Med (1965) 2.34

Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J (1970) 2.33

Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol (1976) 2.25

Monitoring ambulatory blood pressure in general practice. BMJ (1992) 2.19

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet (2007) 2.15

Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14

External method for detection of fetal breathing in utero. Lancet (1971) 2.14

A blood pressure clinic in a health centre. Postgrad Med J (1976) 2.12

Vagus nerve stimulation for symptomatic generalized epilepsy: a pilot study. Epilepsia (1998) 2.08

Disordered gastric motor function in diabetes mellitus. Diabetologia (1994) 2.07

Menses and breast cancer: does timing of mammographically directed core biopsy affect outcome? J Surg Oncol (2000) 2.07

An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens (1993) 1.99

Measurement of blood pressure in children. Recommendations of a working party of the British Hypertension Society. BMJ (1989) 1.95

Medical Investigation of Retinal Vascular Occlusion. Br Med J (1964) 1.93

Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging (2000) 1.91

Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90

Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. J Hypertens (1987) 1.90

Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors. Phys Med Biol (1971) 1.89

Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Br Heart J (1980) 1.88

The estimation of renin in human plasma. Biochem J (1964) 1.85

Essential hypertension: a disorder of growth with origins in childhood? J Hypertens (1992) 1.85

Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension. Br Med J (1966) 1.83

Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet (1985) 1.81

Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab (1998) 1.80

The relation of total body potassium to height, weight, and age in normal adults. J Clin Pathol (1972) 1.80

Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension (1990) 1.77

Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76

Circulating dopamine: its effect on the plasma concentrations of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. Clin Sci (Lond) (1981) 1.76

A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med (1973) 1.76

What proportion of patients refuse consent to data collection from their records for research purposes? Br J Gen Pract (2000) 1.74

Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens (1986) 1.71

Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71

A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(alpha 1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis (1996) 1.70

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69

Captopril/diuretic combinations in severe renovascular disease: a cautionary note. Lancet (1983) 1.68

Captopril: five years on. Br Med J (Clin Res Ed) (1983) 1.68

Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet (1980) 1.68

Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol (1996) 1.67

Renin and acute renal failure: studies in man. Br Med J (1970) 1.66

Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64

Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients. Clin Pharmacol Ther (1980) 1.64

An assessment of radiological criteria used in the study of spinal osteoporosis. Br J Radiol (1967) 1.62

Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension (1980) 1.60

Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens (1992) 1.60

Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging. Radiology (1993) 1.60

Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut (1999) 1.59

Normal insulin response to glucose. Lancet (1966) 1.58

The estimation of renin in plasma by an enzyme kinetic technique. Biochem J (1964) 1.56

Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1992) 1.56

Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler (2008) 1.55

Countercurrent exchange between the vasa recta and the loop of Henle. Lancet (1966) 1.52

Salt and hypertension. Lancet (1984) 1.52

Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut (1994) 1.51

Blood loss in the Kolff twin-coil artificial kidney. Nephron (1970) 1.50